Silverarc Capital Management, LLC has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $353 Million distributed in 70 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $36.9M, Nuvalent, Inc. with a value of $35.3M, Avidity Biosciences, Inc. with a value of $21.1M, Uro Gen Pharma Ltd. with a value of $18.5M, and Erasca, Inc. with a value of $18.4M.
Examining the 13F form we can see an increase of $54.6M in the current position value, from $298M to 353M.
Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.